Aceto pops on robust fiscal Q4 results
Shares of Aceto Corp. (Nasdaq:ACET) popped 9% in pre-market trading after the maker of chemically derived pharmaceuticals and biopharmaceuticals posted robust fiscal fourth-quarter results.
For the three months ended June 20, 2008, the company posted a 90% increase in net income, as sales surged 20% in the quarter. Operating income soared 104.3%.
Shares gained 9%, or $0.75, to $9.26 in pre-market trading. For detailed price information and news stories on Aceto, click ACET.
